Search results
Results from the WOW.Com Content Network
Fosun Group was founded in 1992 as the Guangxin Technology Development Company by five graduates [7] of Fudan University in Shanghai: [8] Guo Guangchang, [9] Liang Xinjun, [10] Wang Qunbin [11] (Chinese: 汪群斌), Fan Wei [12] (Chinese: 范伟), and Tan Jian (Chinese: 谈剑). [9] Fosun started its business by doing market research. [13]
Fosun High Technology also once owned 23.45% of the convertible bond (SSE:100196) of Fosun Pharma in 2003. [10]: 6 As of 31 December 2017, co-founder of Fosun High Technology and now co-owner of the parent company of Fosun International, Guo Guangchang and Wang Qunbin, still served as non-executive directors of Fosun Pharmaceutical.
Guo Guangchang (simplified Chinese: 郭广昌; traditional Chinese: 郭廣昌, born February 1967) is a Chinese businessman and investor.He is the chairman and co-founder of Fosun International Limited, and a representative of the 12th Chinese People's Political Consultative Conference.
Liang was born in 1968 in Taizhou, Zhejiang.He received his B. A. from Fudan University in 1991, and founded Fosun with Guo Guangchang in 1992. In 2007, he received his MBA degree from Cheung Kong Graduate School of Business.
Fan Wei (Chinese: 范伟) is a Chinese businessman and investor.He was one of the founder of Hong Kong incorporated public company Fosun International; he also founded its predecessor, Fosun Group, in the mainland China. [1]
This page was last edited on 15 December 2024, at 15:16 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise.The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group (SEHK: 1099, via a 51–49 joint venture, Sinopharm Industrial Investment, with Fosun Pharmaceutical), China Traditional Chinese Medicine [] (SEHK: 570, mostly via ...
Wang Qunbin (Chinese: 汪群斌; born 1969) is a Chinese billionaire businessman. He was appointed co-chairman of Fosun International in February 2020, and was CEO of Fosun from March 2017 to February 2020, when he replaced Liang Xinjun.